X-71224197-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_000166.6(GJB1):c.490C>T(p.Arg164Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00000249 in 1,203,185 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000091 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )
Consequence
GJB1
NM_000166.6 missense
NM_000166.6 missense
Scores
10
4
3
Clinical Significance
Conservation
PhyloP100: 4.03
Genes affected
GJB1 (HGNC:4283): (gap junction protein beta 1) This gene encodes a member of the gap junction protein family. The gap junction proteins are membrane-spanning proteins that assemble to form gap junction channels that facilitate the transfer of ions and small molecules between cells. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene cause X-linked Charcot-Marie-Tooth disease, an inherited peripheral neuropathy. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM1
In a chain Gap junction beta-1 protein (size 282) in uniprot entity CXB1_HUMAN there are 4 pathogenic changes around while only 0 benign (100%) in NM_000166.6
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.901
PP5
Variant X-71224197-C-T is Pathogenic according to our data. Variant chrX-71224197-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 217170.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-71224197-C-T is described in Lovd as [Pathogenic]. Variant chrX-71224197-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GJB1 | NM_000166.6 | c.490C>T | p.Arg164Trp | missense_variant | 2/2 | ENST00000361726.7 | NP_000157.1 | |
GJB1 | NM_001097642.3 | c.490C>T | p.Arg164Trp | missense_variant | 2/2 | NP_001091111.1 | ||
GJB1 | XM_011530907.3 | c.490C>T | p.Arg164Trp | missense_variant | 2/2 | XP_011529209.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GJB1 | ENST00000361726.7 | c.490C>T | p.Arg164Trp | missense_variant | 2/2 | 1 | NM_000166.6 | ENSP00000354900.6 |
Frequencies
GnomAD3 genomes AF: 0.00000909 AC: 1AN: 109963Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32205
GnomAD3 genomes
AF:
AC:
1
AN:
109963
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32205
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000582 AC: 1AN: 171957Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 58379
GnomAD3 exomes
AF:
AC:
1
AN:
171957
Hom.:
AF XY:
AC XY:
0
AN XY:
58379
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000183 AC: 2AN: 1093222Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 359346
GnomAD4 exome
AF:
AC:
2
AN:
1093222
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
359346
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000909 AC: 1AN: 109963Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 32205
GnomAD4 genome
AF:
AC:
1
AN:
109963
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
32205
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 29, 2016 | The R164W pathogenic variant has been published numerous times in association with CMT (Ionasescu et al., 1995; Ionasescu et al., 1996; Oterino et al., 1996; Young et al., 2001). Functional studies using dual whole-cell voltage-clamp recordings show that R164W impaired the formation and function of junctional channels (Wang et al., 2004). Additionally, different amino acid substitutions at this same position (R164G/Q) and in nearby residues have been reported in the Human Gene Mutation Database in association with CMT (Stenson et al., 2014), supporting the functional significance of this region of the protein. R164W was not observed with any significant frequency in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. R164W is a non-conservative amino acid substitution, which occurs at a position that is conserved across species. Therefore, R164W is interpreted to be a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 27, 2023 | The frequency of this variant in the general population is consistent with pathogenicity (Genome Aggregation Database (gnomAD), Cambridge, MA (URL: http://gnomad.broadinstitute.org)). This variant has been identified in multiple individuals with clinical features associated with this gene and appears to be associated with disease in at least one family. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 15006706) The variant is located in a region that is considered important for protein function and/or structure. - |
Charcot-Marie-Tooth Neuropathy X Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 23, 2023 | The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 164 of the GJB1 protein (p.Arg164Trp). Experimental studies have shown that this missense change affects GJB1 function (PMID: 11571214, 15006706). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg164 amino acid residue in GJB1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9187667, 25025039, 27844031). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GJB1 protein function. ClinVar contains an entry for this variant (Variation ID: 217170). This variant is also known as c.552C>T. This missense change has been observed in individuals with Charcot-Marie-Tooth disease (CMT) (PMID: 7580242, 8733054, 11437164, 28469099). It has also been observed to segregate with disease in related individuals. - |
Charcot-Marie-Tooth disease X-linked dominant 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Mar 11, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;D;D;D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;.;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
M;M;M;M;M
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;.;D;.;D
REVEL
Pathogenic
Sift
Benign
T;.;T;.;T
Sift4G
Benign
T;.;T;.;T
Polyphen
D;D;D;D;D
Vest4
MVP
MPC
1.9
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at